Development of nanostars as a biocompatible tumor contrast agent: toward in vivo SERS imaging

dc.contributor.author	D'Hollander, Antoine
dc.contributor.author	Mathieu, Evelien
dc.contributor.author	Jans, Hilde
dc.contributor.author	Vande Velde, Greetje
dc.contributor.author	Stakenborg, Tim
dc.contributor.author	Van Dorpe, Pol
dc.contributor.author	Himmelreich, Uwe
dc.contributor.author	Lagae, Liesbet
dc.contributor.imecauthor	D'Hollander, Antoine
dc.contributor.imecauthor	Jans, Hilde
dc.contributor.imecauthor	Stakenborg, Tim
dc.contributor.imecauthor	Van Dorpe, Pol
dc.contributor.imecauthor	Lagae, Liesbet
dc.contributor.orcidimec	Stakenborg, Tim::0000-0001-9878-9078
dc.contributor.orcidimec	Van Dorpe, Pol::0000-0003-0918-1664
dc.date.accessioned	2021-10-23T10:37:01Z
dc.date.available	2021-10-23T10:37:01Z
dc.date.issued	2016
dc.identifier.issn	1178-2013
dc.identifier.uri	https://imec-publications.be/handle/20.500.12860/26559
dc.identifier.url	https://www.dovepress.com/articles.php?article_id=28258
dc.source.beginpage	3703
dc.source.endpage	3714
dc.source.journal	International Journal of Nanomedicine
dc.source.volume	11
dc.title	Development of nanostars as a biocompatible tumor contrast agent: toward in vivo SERS imaging
dc.type	Journal article
dspace.entity.type	Publication
Files
Publication available in collections:	Articles

Date